Myeloproliferative Disorders

Myeloproliferative disorders require careful review of clinical history, spleen size, symptoms, blood counts and thrombotic or bleeding risk.

Molecular testing and marrow assessment may be needed to classify disease and guide risk-adapted management.

Follow-up should monitor blood-count control, symptom burden, treatment tolerance and transformation signals.